Elazer R Edelman
CIK 1662771 · last filed 2026-06-22
Elazer R Edelman is a corporate insider who has filed 9 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for BFLY, was dated Jun 22, 2026. Current disclosed insider exposure totals $3.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.20M
3
9
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BFLY | Director | 392,893 | $8.13 | $3.20M | $0 | 1 | 2026-06-22 |
| Butterfly Network, Inc. (BFLY.WS) Delisted | Director | 367,446 | $0.01 | $1.9K | $0 | 6 | 2025-06-17 |
| Echo Therapeutics, Inc. (ECTE) Delisted | Director | — | — | — | $0 | 2 | 2016-03-22 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-22 | BFLY | Grant (A) | +25,447 | $0 | EDGAR |
| 2025-06-17 | Butterfly Network, Inc. (BFLY.WS) Delisted | Grant (A) | +80,434 | $0 | EDGAR |
| 2024-06-12 | Butterfly Network, Inc. (BFLY.WS) Delisted | Grant (A) | +157,894 | $0 | EDGAR |
| 2023-06-22 | Butterfly Network, Inc. (BFLY.WS) Delisted | Grant (A) | +65,789 | $0 | EDGAR |
| 2022-06-22 | Butterfly Network, Inc. (BFLY.WS) Delisted | Grant (A) | +48,231 | $0 | EDGAR |
| 2021-07-02 | Butterfly Network, Inc. (BFLY.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-15 | Butterfly Network, Inc. (BFLY.WS) Delisted | Grant (A) | +15,098 | $0 | EDGAR |
| 2016-03-22 | Echo Therapeutics, Inc. (ECTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-03-03 | Echo Therapeutics, Inc. (ECTE) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.